Meitar represented Enzymotec Ltd., a developer of lipid-based products and solutions for the nutritional and healthcare markets, in its initial public offering on NASDAQ raising approximately $70M (including exercise at closing of the underwriters’ overallotment option in full). Bank of America Merrill Lynch and Jefferies LLC acted as joint book-running managers for the offering.
Meitar represented New York/London-based private equity firm Rhone Capital LLC in its acquisition of the European and Israeli operations of Eden Springs for approximately $90 million, based on an enterprise value of Euro 300 million.
Meitar represented Stratasys Ltd. (SSYS) in a public offering of ordinary shares for approximately $481M on NASDAQ with JP Morgan as sole-book-runner and Piper Jaffray, Morgan Stanley, Bank of America Merrill Lynch and Needham as co-managers.
Meitar represented a leading 3D printing company, Stratasys, Ltd. (NASDAQ:SSYS) in its acquisition of MakerBot, the Brooklyn NY-based leader in desktop 3D printing, in a stock-for-stock swap, valued at approximately $403 million, with additional contingent performance-based payments valued at approximately $201M.
Our firm represented ROTH Capital partners in the $20 million follow on offering by Attunity Ltd. on NASDAQ.
Meitar represented Covidien, a U.S. medical device manufacturer, in its acquisition of SuperDimension, an Israeli company with a cutting-edge technology for minimally-invasive surgical procedures on the lungs, for $300 million in cash, with future earn out payments possible. The transaction is expected to be completed during the second quarter of 2012.
Meitar represented Singapore Telecom, Southeast Asia’s largest telecom company, in its acquisition of Amobee, a mobile advertising company, for approximately $320 million in cash. The transaction is expected to be completed during the second quarter of 2012.
